Genetic Signatures and Microba agree principal terms for all-scrip merger

Genetic Signatures ASX:GSS and Microba Life Sciences ASX:MAP have agreed principal commercial terms for an all-scrip merger that would create a larger Australian diagnostics group with complementary technologies, products and international distribution networks. The proposed scheme of arrangement would combine the two businesses under the terms outlined in the announcement.